Politico October 30, 2024
Erin Schumaker, Daniel Payne and Ruth Reader

THE LAB

The Department of Veterans Affairs remains convinced that psychedelic therapy can help treat veterans with post-traumatic stress disorder — and it’s going to try to prove it.

That commitment comes despite the FDA’s August rejection of a drug company’s plan to offer a psychedelic regimen for PTSD.

How so? The VA is funding a study on whether MDMA, also known as ecstasy, combined with talk therapy is an effective treatment for PTSD and alcohol-use disorder, Dr. Shereef Elnahal, the VA undersecretary for health, announced on LinkedIn.

The U.S. Department of Veterans Affairs must lead on this encouraging area of investigation so that we can continue to build trust with Veterans contending with these severe health conditions,” he wrote,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Mental Health, Provider, VA / DoD
How the VA is Quietly Innovating and Leading in Virtual Care and Remote Patient Monitoring
Changing Affairs: VA Expects Change During Trump Administration
Study finds 1 in 4 older U.S. veterans report cardiovascular disease diagnosis
Cigna Group Foundation Grants $9 Million for Veteran Housing, Mental Stability
DoD to develop scalable genAI testing datasets

Share This Article